![Alexandra Glucksmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexandra Glucksmann
Directeur/Membre du Conseil chez
REGENXBIO INC.
Fortune : 279 663 $ au 31/07/2026
Profil
Alexandra Glucksmann is currently Chairman at Women Entrepreneurs In Science & Technology, Independent Director at REGENXBIO, Inc. since 2018, Independent Non-Executive Director at Scenic Biotech BV since 2017, and Director at Sensorium Therapeutics, Inc. starting in 2023.
Former roles include President, Chief Executive Officer & Director at Cedilla Therapeutics, Inc. from 2018 to 2022; Director at Taconic Biosciences, Inc. from 2006 to 2015; Vice President-Technology at Millennium Pharmaceuticals, Inc. from 1993 to 2006; Principal at Third Rock Ventures LLC from 2017 to 2018; Senior Vice President-Research & Development at Cerulean Pharma, Inc. from 2012 to 2013; Member-Supervisory Board at TME Pharma NV from 2024 to 2025; and Chief Operating Officer at Editas Medicine, Inc. from 2015 to 2017.
Education includes a doctorate from The University of Chicago conferred in 1989 and undergraduate studies at the University of Wisconsin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
REGENXBIO, INC. 0,04 % | 29/05/2026 | 28 861 ( 0,04 % ) | 279 663 $ | 31/07/2026 |
Postes actifs de Alexandra Glucksmann
| Sociétés | Poste | Début |
|---|---|---|
| REGENXBIO INC. | Directeur/Membre du Conseil | 25/05/2018 |
Women Entrepreneurs In Science & Technology | Président | - |
Scenic Biotech BV
 Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Develops therapies for patients using genomics | Directeur/Membre du Conseil | 01/09/2017 |
Sensorium Therapeutics, Inc.
 Sensorium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for mental illness | Directeur/Membre du Conseil | 08/07/2025 |
Anciens postes connus de Alexandra Glucksmann
| Sociétés | Poste | Fin |
|---|---|---|
| TME PHARMA N.V. | Directeur/Membre du Conseil | 25/06/2025 |
Cedilla Therapeutics, Inc.
 Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovering and exploiting unique insights into protein stability | Directeur Général | 01/11/2022 |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Corporate Officer/Principal | 01/03/2018 |
| EDITAS MEDICINE, INC. | Directeur des opérations | 01/03/2017 |
Taconic Biosciences, Inc.
 Taconic Biosciences, Inc. BiotechnologyHealth Technology Develops genetically engineered rodent models and humanized immune system mice for immuno-oncology, immunology, neuroscience and metabolic disease research | Directeur/Membre du Conseil | 01/05/2015 |
Formation de Alexandra Glucksmann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
Taconic Biosciences, Inc.
Taconic Biosciences, Inc. BiotechnologyHealth Technology Develops genetically engineered rodent models and humanized immune system mice for immuno-oncology, immunology, neuroscience and metabolic disease research | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Health Technology |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
Women Entrepreneurs In Science & Technology | |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
TME Pharma NV
 TME Pharma NV BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Scenic Biotech BV
Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Develops therapies for patients using genomics | Commercial Services |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovering and exploiting unique insights into protein stability | Health Technology |
Sensorium Therapeutics, Inc.
Sensorium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for mental illness | Health Technology |
